⌘K

Login Start Free

Home/Filings/4/0001415889-25-015642

4//SEC Filing

Farnum Rhonda 4

Accession 0001415889-25-015642

CIK 0001583107other

View on SEC.gov Company Profile

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 6:04 PM ET

Size

4.7 KB

Accession

0001415889-25-015642

Insider Transaction Report

Form 4

Period: 2025-06-02

Theravance Biopharma, Inc.TBPH

SVP, COMM & MEDICAL AFFAIRS

Transactions

Sale
Ordinary Shares
2025-06-02$11.00/sh−24,000$264,000→ 336,918 total

Documents

1 file

4
form4-06042025_100617.xmlPrimary

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1

filerCIK 0001898490

Filing Metadata

Form type: 4
Filed: Jun 3, 8:00 PM ET
Accepted: Jun 4, 6:04 PM ET
Size: 4.7 KB

View on SEC.gov